Precision Medicine Industry (Market) Growth Analysis By Top Key Players IBM, Illumina, Roche, Novartis, Almac Group, Biomrieux Sa, Cepheid, Qiagen, Healthcore

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people.

For Sample Copy of this Report @ https://www.orianresearch.com/request-sample/804799

The report includes Different parts, dealing with:

Basic information
Precision Medicine industry analysis
Market entry and investment feasibility analysis
Report conclusion.

The Major Key Players Coverage (Sales data, Main Products & Services etc.):

Johnson & Johnson
IBM
GE Healthcare
Illumina
Roche
Laboratory Corporation of America Holdings
Thermo Fisher Scientific
Novartis
Abbott Laboratories
Almac Group
…

Global Precision Medicine Industry is spread across 136 pages, profiling 16 companies and supported with tables and figures.

Inquire more or share a question if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/804799 .

Product Type Coverage (Market Size & Forecast, Major Business of Product Type etc.):

Diagnostics
Therapies

Product Applications (Industry Size & Forecast, Consumer Distribution):

Oncology
Neurosciences
Immunology
Respiratory
Others

Scope of the Report:

It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals

Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.  

Order a copy of Global Precision Medicine Market Report 2019 @ https://www.orianresearch.com/checkout/804799 .

The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics in 2016 is about 68%.

Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the revenue in 2016 is 4.3 billion USD.

Germany is the largest consumption place, with a consumption market share nearly 22% in 2016. Following Germany, France is the second largest consumption place with the consumption market share of 18%.

The worldwide market for Precision Medicine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.

This report focuses on the Precision Medicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

About Us
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:
Ruwin Mendez
Vice President – Global Sales & Partner Relations
Orian Research Consultants
US +1 (415) 830-3727| UK +44 020 8144-71-27
Email: info@orianresearch.com
Website: www.orianresearch.com/
Follow Us on LinkedIn: https://www.linkedin.com/company-beta/13281002/

This release was published on openPR.